We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Michael J. Fox Foundation Extends Funding for KineMed’s Brain-Process Biomarker Research for PD

News   Jun 29, 2012

 
The Michael J. Fox Foundation Extends Funding for KineMed’s Brain-Process Biomarker Research for PD
 
 
 

RELATED ARTICLES

Chemical Reaction Method Makes Drug Production More Efficient

News

Researchers have created a more efficient method to produce the building blocks needed for cancer treatment drugs and antibiotics.

READ MORE

Biomarker Identified for Early Beta Cell Death in Type 1 Diabetes

News

Anath Shalev, M.D., and colleagues at the University of Alabama at Birmingham have identified an early biomarker of Type 1 diabetes-associated beta-cell loss in humans — miR-204. “Serum miR-204,” Shalev said, “may provide a much needed novel approach to assess early Type 1 diabetes-associated human beta-cell loss, even before onset of overt disease.”

READ MORE

Novel Drug Candidate Designed, Synthesized and Validated in 46 Days Using AI

News

A team of researchers has successfully used Artificial Intelligence to design, synthesize and validate a novel drug candidate in just 46 days, compared to the typical 2-3 years required using the standard hit to lead approach.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE